Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 826 participants.

Also called NCT04452149

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 826 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT04452149
Other papers using this trial's data
  • Arrhythmia Burden and Clinical Responses Under Continuous Monitoring in Heart Failure: Observations From the ALLEVIATE-HF Trial Journal of the American College of Cardiology, 2026-06-30 DOI, PubMed 42201276
  • Risk-Based Nurse-Managed Personalized Heart Failure Interventions: The ALLEVIATE-HF Trial Journal of the American College of Cardiology, 2026-06-30 DOI, PubMed 42201288

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04452149. Randomized; quadruple masking; primary purpose treatment. Start 2020-09-03 (actual); primary completion 2025-06-02 (actual). Results posted on 2026-08-26.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure
Acronym
ALLEVIATE-HF
Condition
Heart Failure NYHA Class II
Condition
Heart Failure NYHA Class III
Intervention (Device)
Reveal LINQ™ Insertable Cardiac Monitor with investigational ALLEVIATE-HF RAMware download
Intervention (Other)
Medication intervention
Intervention (Other)
Not Randomized to Device or Medication Intervention
Lead sponsor
Medtronic Cardiac Rhythm and Heart Failure (class: industry)

Record details

Record id
cardio:ct-nct04452149
Content hash
3d4e50bf5ea4fb18c519230a74c2e06ddb37926421f3f56e8c689a9fc134cb8b